With acquisition, vision and deep pockets, Kriya Therapeutics eyes new day for gene therapy

San Francisco Business Journal

Nov 16, 2022

One of the acquired programs - coupling gene therapy with the generic smoking cessation drug Chantix to quell hyperactive neurons in epilepsy patients - could be ready for a clinic…